Hereditary Breast Ovarian Cancer Syndrome, also known as hereditary breast and ovarian cancer syndrome, is related to fallopian tube carcinoma and breast-ovarian cancer, familial 1. An important gene associated with Hereditary Breast Ovarian Cancer Syndrome is BRCA2 (BRCA2 DNA Repair Associated), and among its related pathways/superpathways are Gene expression (Transcription) and Infectious disease. The drugs Paclitaxel and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include breast and ovary, and related phenotypes are ovarian neoplasm and primary peritoneal carcinoma